Mechanisms of resistance to HER2-targeted therapies in HER2-amplified uterine serous carcinoma, and strategies to overcome it.
This study presents a comprehensive review of the mechanisms of USC resistance to HER2-targeted therapies and potential strategies to overcome it.
PMID: 30265854 [PubMed - in process]
Source: Discovery Medicine - Category: Research Tags: Discov Med Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Chemotherapy | Endometrial Cancer | HER2 | Herceptin | Men | Research | Serous Carcinoma | Study